Possible agent for COVID-19 treatment: Rifampicin

Rifampicin is a promising drug for the treatment of coronavirus disease 2019 based on its antiviral properties and recent studies. studies can serve as a foundation for further studies.

Saved in:

Bibliographic Details
Published in	World journal of virology Vol. 11; no. 5; pp. 391 - 393
Main Authors	Aydin, Ozlem Celik, Aydın, Sonay, Barun, Sureyya
Format	Journal Article
Language	English
Published	United States Baishideng Publishing Group Inc 25.09.2022
Subjects	Letter to the Editor COVID-19 In silico Rifampicin Treatment Drug-drug interaction Therapeutic potential
Online Access	Get full text

Cover

Loading…

Be the first to leave a comment!